Andere talen Ind-Swift Laboratories Limited

Aandelen

INDSWFTLAB

INE915B01019

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:52 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
110,3 ^INR	-1,30%		+4,55%	+6,52%

13/05	Ind-Swift Laboratories Limited rapporteert resultaten voor het vierde kwartaal dat eindigde op 31 maart 2024	CI
19/04	Ind-Swift Laboratories Limited kondigt de oprichting aan van een volle dochteronderneming	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	13/05
Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai	19/04
Ind-Swift Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	19/04
Ind-Swift Laboratories Limited Announces Cessation of Sunil Deshmukh as Chief Executive Officer	18/03
Ind-Swift Laboratories Limited Announces Cessation of Lovekesh Mahajan as Chief Accounts Officer	18/03
Ind-Swift Laboratories Limited Redeems in Full, the 4245 Rated, Listed, Secured, 10% Coupon, Redeemable, Non-Convertible Debenture	18/03
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited and Essix Biosciences Limited.	18/03
Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
CARE Keeps BB Rating on Ind-Swift Laboratories' Long-term Financing; Rating Under Watch Developing	20/12
Ind-Swift Laboratories Limited Collaborates with The Council of Scientific and Industrial Research	29/11
Ind-Swift Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023	07/11
Ind-Swift Laboratories Limited agreed to acquire Ind-Swift Limited.	25-09-23
IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores	07-09-23
Ind-Swift Gets Board Nod to Secure INR6 Billion Loan from Ind-Swift Laboratories	06-09-23
India's Ind-Swift Labs to sell pharma ingredients ops for $198.5 million	06-09-23
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 16.5 billion.	06-09-23
Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09-08-23
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29-05-23
RN Chemicals & Pharmaceutical Private Limited acquired Halcyon life Sciences Private Limited from Ind-Swift Laboratories Limited for INR 5 million.	30-03-23
Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ind-Swift Laboratories Limited

Aandelen

INDSWFTLAB

INE915B01019

Andere talen

Filters